HDL nanoparticles (Northwestern University/AuraSense-HDL)

N/A

Report date: 2025/03/20 14:50:31

Base Information

Drug NameHDL nanoparticles (Northwestern University/AuraSense-HDL)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCholesterol modulatorsScavenger receptor class B member 1 modulators
TargetsScavenger receptor class B member 1Cholesterol
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesAuraSense-HDLNorthwestern University
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A